Top-selling biotech drugs based on revenue 2017
Top selling biotech drugs worldwide in 2017 (in billion U.S. dollars)
This statistic shows a ranking of the top 10 best-selling biotech drugs worldwide in 2017. In that year, Enbrel generated a revenue of some 7.9 billion U.S. dollars for co-marketing companies Amgen, Pfizer, Takeda (Japan), and Wyeth (rest of world), and thus was the world's third biotech drug based on revenue.
Best-selling biotech drugs worldwide
AbbVie’s Humira and Roche's Rituxan are among the top selling biotechnology drugs in the world, generating 18.4 billion U.S. dollars and 9.2 billion U.S. dollars, respectively, in 2017. Biotechnology has become more prevalent within the pharmaceutical industry. One of the first uses of biotechnology was for human insulin. The United States had around 860 dedicated biotechnology companies in 2015. However, one of the largest biotechnology companies in the world is headquartered in Basel, Switzerland. Roche generated some 34 billion U.S. dollars in biotech prescription drug revenues in 2017 and is expected to reach 42 billion U.S. dollars in 2024. One of their top selling drugs, Avastin, generated about 7.1 billion U.S. dollars in revenue in 2017. Avastin is a drug derived from biotechnology that is used to inhibit the growth of new blood vessels to treat some types of cancer.
The United States spent about 28.6 billion U.S. dollars on research and development in the biotechnology sector. The United States has also had about 34 percent of the world’s share of filed biotechnology patents in 2014, in comparison, Germany filed eight percent of global biotech patents.
Top selling biotech drugs worldwide in 2017 (in billion U.S. dollars)
Source
More information
Statistics on "Biotech industry"
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Italy: number of biotech drugs marketed 2016-2017, by type
- Italy: number of patients treated with biological medicaments 2018, by disease
- Insulin-replacement medications - revenues 2010
- Biotech drugs - revenues
- Italy: turnover of biotech drugs 2014-2017
- Italy: value of investments in R&D of biotech pharma companies 2014-2017
- Italy: number of R&D employees of biotech pharma companies 2014-2017
- U.S. bioscience employment totals 2016
- Latin America: chromatography instrumentation revenue 2018-2023
- U.S. metropolitan areas by employment in research and medical laboratories 2016
- U.S. bioscience employment by subsector 2016
- U.S. bioscience employment distribution 2016 by subsector
- Italy: number of biotech companies in the pharma sector 2014-2017
- U.S. bioscience establishments totals 2016
- Number of U.S. bioscience establishments by subsectors 2016
- Number of biotechnology patents in Portugal 2005-2016
- U.S. public bioscience firms by revenue size class
- Argentina: pharma exports 2016-2017, by type of medicine
- Industry revenue of »research, experimental development on biotechnology« in Romania 2011-...
- Industry revenue of »research, experimental development on biotechnology« in Austria 2011-...
Statistics on "Biotech industry"
Related topics
About Statista
